Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Pradeep, Sunila | - |
dc.contributor.author | Kim, Seung W. | - |
dc.contributor.author | Wu, Sherry Y. | - |
dc.contributor.author | Nishimura, Masato | - |
dc.contributor.author | Chaluvally-Raghavan, Pradeep | - |
dc.contributor.author | Miyake, Takahito | - |
dc.contributor.author | Pecot, Chad V. | - |
dc.contributor.author | Kim, Sun-Jin | - |
dc.contributor.author | Choi, Hyun Jin | - |
dc.contributor.author | Bischoff, Farideh Z. | - |
dc.contributor.author | Mayer, Julie Ann | - |
dc.contributor.author | Huang, Li | - |
dc.contributor.author | Nick, Alpa M. | - |
dc.contributor.author | Hall, Carolyn S. | - |
dc.contributor.author | Rodriguez-Aguayo, Cristian | - |
dc.contributor.author | Zand, Behrouz | - |
dc.contributor.author | Dalton, Heather J. | - |
dc.contributor.author | Arumugam, Thiruvengadam | - |
dc.contributor.author | Lee, Ho Jeong | - |
dc.contributor.author | Han, Hee Dong | - |
dc.contributor.author | Cho, Min Soon | - |
dc.contributor.author | Rupaimoole, Rajesha | - |
dc.contributor.author | Mangala, Lingegowda S. | - |
dc.contributor.author | Sehgal, Vasudha | - |
dc.contributor.author | Oh, Sang Cheul | - |
dc.contributor.author | Liu, Jinsong | - |
dc.contributor.author | Lee, Ju-Seog | - |
dc.contributor.author | Coleman, Robert L. | - |
dc.contributor.author | Ram, Prahlad | - |
dc.contributor.author | Lopez-Berestein, Gabriel | - |
dc.contributor.author | Fidler, Isaiah J. | - |
dc.contributor.author | Sood, Anil K. | - |
dc.date.accessioned | 2021-09-05T07:04:40Z | - |
dc.date.available | 2021-09-05T07:04:40Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2014-07-14 | - |
dc.identifier.issn | 1535-6108 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/97967 | - |
dc.description.abstract | Ovarian cancer has a clear predilection for metastasis to the omentum, but the underlying mechanisms involved in ovarian cancer spread are not well understood. Here, we used a parabiosis model that demonstrates preferential hematogenous metastasis of ovarian cancer to the omentum. Our studies revealed that the ErbB3-neuregulin 1 (NRG1) axis is a dominant pathway responsible for hematogenous omental metastasis. Elevated levels of ErbB3 in ovarian cancer cells and NRG1 in the omentum allowed for tumor cell localization and growth in the omentum. Depletion of ErbB3 in ovarian cancer impaired omental metastasis. Our results highlight hematogenous metastasis as an important mode of ovarian cancer metastasis. These findings have implications for designing alternative strategies aimed at preventing and treating ovarian cancer metastasis. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | CELL PRESS | - |
dc.subject | EPITHELIAL OVARIAN | - |
dc.subject | CHEMOTHERAPY | - |
dc.subject | BEVACIZUMAB | - |
dc.subject | EXPRESSION | - |
dc.subject | CARCINOMA | - |
dc.subject | ESTROGEN | - |
dc.subject | RECEPTOR | - |
dc.subject | TRIAL | - |
dc.subject | RNA | - |
dc.title | Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Oh, Sang Cheul | - |
dc.identifier.doi | 10.1016/j.ccr.2014.05.002 | - |
dc.identifier.scopusid | 2-s2.0-84904265681 | - |
dc.identifier.wosid | 000339305200013 | - |
dc.identifier.bibliographicCitation | CANCER CELL, v.26, no.1, pp.77 - 91 | - |
dc.relation.isPartOf | CANCER CELL | - |
dc.citation.title | CANCER CELL | - |
dc.citation.volume | 26 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 77 | - |
dc.citation.endPage | 91 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | EPITHELIAL OVARIAN | - |
dc.subject.keywordPlus | CHEMOTHERAPY | - |
dc.subject.keywordPlus | BEVACIZUMAB | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | CARCINOMA | - |
dc.subject.keywordPlus | ESTROGEN | - |
dc.subject.keywordPlus | RECEPTOR | - |
dc.subject.keywordPlus | TRIAL | - |
dc.subject.keywordPlus | RNA | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.